Jenny Bryan
- News
Bring on the clones
Once thought of as beyond the pale, the cloning of human embryos is now being encouraged by the government. Jenny Bryan looks at what's in store
- News
Type-righting lessons
The huge rise in the type-2 diabetes population - and the introduction of major new drug treatments - is set to pose some increasingly tough management decisions, writes Jenny Bryan
- News
Rays of hope
Improved imaging techniques mean radiotherapy is potentially capable of saving many more lives - but staff shortages and lack of equipment are hampering progress, writes Jenny Bryan
- News
Dramatic licence
Cancer patients are not benefiting from the large number of new drugs available because purchasers will be reluctant to fund them until they have the NICE seal of approval. Jenny Bryan squares the circle
- News
The long goodbye
Reaching a 100th birthday will soon become a commonplace event. But the centenarians of the new millennium will not be the chronic sick and long-stayers of managers worst nightmares, writes Jenny Bryan
- News
Reverting to type
In time, patients' genetic profiles may be checked to ensure new treatments go to those who will benefit most, writes Jenny Bryan
- News
Hard graft
Patients with end-stage renal failure may be overjoyed to receive a donor kidney - but it is only the start of the battle to prevent rejection and keep the patient well. Jenny Bryan looks at drug treatments that can help